Assertio Holdings (ASRT) Other Operating Expenses (2020 - 2026)
Assertio Holdings' (ASRT) quarterly Other Operating Expenses came in at $8.4 million in Q1 2026, down 50.23% year-on-year from $16.9 million in Q1 2025, and up 202.62% quarter-over-quarter from -$8.2 million in Q2 2025.
Assertio Holdings (ASRT) Other Operating Expenses (2020 - 2026) Analysis & Trends
Assertio Holdings has disclosed Other Operating Expenses across 6 years of filings, most recently posting $8.4 million for Q1 2026.
- Other Operating Expenses for Q1 2026 came in at $8.4 million, down 50.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $215000.0 (down 98.73% YoY), and the FY2025 annual result was -$8.2 million, changed N/A from the prior year.
- Other Operating Expenses came in at $8.4 million for Q1 2026 at Assertio Holdings, up from -$8.2 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $238.4 million in Q3 2023 to a low of -$8.2 million in Q2 2025.
- The 5-year median for Other Operating Expenses is $16.2 million (2022), against an average of $34.6 million.
- Across the five-year window, Other Operating Expenses jumped 1420.46% in 2023 and slumped 50.23% in 2026, its largest moves.
- Assertio Holdings' Other Operating Expenses stood at $25.8 million in 2022, then surged by 61.72% to $41.8 million in 2023, then sank by 59.95% to $16.7 million in 2024, then tumbled by 149.02% to -$8.2 million in 2025, then surged by 202.62% to $8.4 million in 2026.
- The last three Other Operating Expenses figures came in at $8.4 million (Q1 2026), -$8.2 million (Q2 2025), and $16.9 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Assertio Holdings | 150.94 Mn | 79.37 Mn | 7.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.42 Mn |
| Jun 30, 2025 | -8.20 Mn |
| Mar 31, 2025 | 16.91 Mn |
| Mar 31, 2024 | 16.73 Mn |
| Dec 31, 2023 | 41.77 Mn |
| Sep 30, 2023 | 238.38 Mn |
| Jun 30, 2023 | 11.10 Mn |
| Mar 31, 2023 | 20.72 Mn |
| Dec 31, 2022 | 25.83 Mn |
| Sep 30, 2022 | 15.68 Mn |
| Jun 30, 2022 | 13.60 Mn |
| Mar 31, 2022 | 14.14 Mn |
| Dec 31, 2020 | 13.85 Mn |
| Jun 30, 2020 | -850,000.00 |
| Mar 31, 2020 | -15.76 Mn |